Liu Zhao, Lang Jinghe, Wu Ming, Li Lei
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China.
Department of Obstetrics and Gynecology, Beijing Aerospace General Hospital, Beijing, China.
Front Oncol. 2021 Feb 16;10:618499. doi: 10.3389/fonc.2020.618499. eCollection 2020.
Retrospective cohort study.
Debates remain regarding the role of lymphadenectomy in patients with apparent stage IA endometrial cancer, especially subtypes with a favorable prognosis. This study aimed to explore the prognostic value of staging surgeries in apparent stage IA endometrial endometrioid cancer patients in a retrospective cohort study.
Cases from June 1, 2010 to June 1, 2017 were reviewed in patients with pathologically confirmed endometrial endometrioid carcinoma limited to <1/2 of the myometrium, without extrauterine metastasis on preoperative evaluation and during surgical inspection. Survival outcomes were compared between patients with and without lymphadenectomy and between patients with and without metastasis to lymph nodes.
In total, 1,312 eligible patients were included, among which 836 underwent staging surgeries and 476 underwent simple hysterectomy. Twenty-eight patients were found with metastasis to retroperitoneal lymph nodes. After a median follow-up of 57.4 months, lost to follow-up, recurrence, death, and cancer-specific death occurred in 28, 39, 24, and 16 patients, respectively. In a univariate analysis, lymphadenectomy of the pelvis with or without para-aortic lymph nodes had no significant impact on disease-free survival, overall survival or cancer-specific overall survival ( values >0.05). However, after adjusting for important baseline risk factors [menopausal status, tumor differentiation, maximum diameter and location, lymph-vascular space invasion (LVSI) status, and postoperative adjuvant therapy), lymphadenectomy resulted in significantly improved survival outcomes ( values <0.05). Menopause (odds ratio [OR] 4.7, 95% confidence interval [CI] 1.3-16.4, =0.015), tumor diameter larger than 2 cm (OR 4.6, 95% CI 1.3-16.0, =0.016), grade 3 tumors (OR 3.0, 95% CI 1.0-8.5, =0.042), positive LVSI (OR 8.7, 95% CI 3.7-20.4, <0.001) and lower uterine segment involvement (OR 3.1, 95% CI 1.4-7.2, =0.007) had more extrauterine metastases.
In cases of apparent stage IA endometrioid endometrial carcinoma, staging surgeries should be considered in patients with larger, higher grade tumors, positive LVSI, or lower uterine segment involvement.
回顾性队列研究。
关于淋巴结切除术在明显IA期子宫内膜癌患者,尤其是预后良好亚型患者中的作用,仍存在争议。本项回顾性队列研究旨在探讨分期手术对明显IA期子宫内膜样腺癌患者的预后价值。
回顾2010年6月1日至2017年6月1日期间的病例,这些患者经病理证实为子宫内膜样癌,肿瘤局限于子宫肌层的<1/2,术前评估及手术探查均无子宫外转移。比较有或无淋巴结切除术患者以及有或无淋巴结转移患者的生存结局。
共纳入1312例符合条件的患者,其中836例行分期手术,476例行单纯子宫切除术。发现28例患者有腹膜后淋巴结转移。中位随访57.4个月后,分别有28例、39例、24例和16例患者失访、复发、死亡及癌症特异性死亡。单因素分析中,盆腔淋巴结切除术(无论是否清扫腹主动脉旁淋巴结)对无病生存期、总生存期或癌症特异性总生存期均无显著影响(P值>0.05)。然而,在调整重要的基线危险因素(绝经状态、肿瘤分化程度、最大直径及位置、淋巴血管间隙浸润(LVSI)状态和术后辅助治疗)后,淋巴结切除术可显著改善生存结局(P值<0.05)。绝经(比值比[OR] 4.7,95%置信区间[CI] 1.3 - 16.4,P = 0.015)、肿瘤直径大于2 cm(OR 4.6,95% CI 1.3 - 16.0,P = 0.016)、3级肿瘤(OR 3.0,9% CI 1.0 - 8.5,P = 0.042)、LVSI阳性(OR 8.7,95% CI 3.7 - 20.4,P<0.001)以及子宫下段受累(OR 3.1,95% CI 1.4 - 7.2,P = 0.007)的患者有更多子宫外转移。
对于明显IA期子宫内膜样腺癌患者,肿瘤较大、分级较高、LVSI阳性或子宫下段受累的患者应考虑分期手术。